ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 621855 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 621855; 2) Community: the network communities that were significantly associated with the response to NSC 621855; 3) Molecule: the relationships between components within communities and NSC 621855; 4) MDR: the compounds that were significantly associated with the NSC 621855.

NSC Compound Enrichment Correlation
NSC 748705 Null 0.0422011701988039 0.32022676
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0422011701988039 0.14875519
NSC 751958 (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate 0.0422011701988039 0.24061322
NSC 753734 7alpha-acetoxyroylenane 0.0422011701988039 0.077921566
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.0422011701988039 0.23607075
NSC 757387 ACRIFLAVINIUM HYDROCHLORIDE 0.0422011701988039 0.10128868
NSC 77039 Null 0.0422011701988039 0.20766015
NSC 87500 Solacongestidine 0.0422011701988039 0.28526235
NSC 741738 1-(7-Methoxy-3-methyl-1,4-dioxy-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.0422011701988042 -0.23712652
NSC 746149 N,N'-bis(4-bromo-2-fluorobenzoyl)-L-selenocystine bis(4-methoxyphenacyl) ester hemihydrate 0.0422011701988042 -0.18983804
Total:97  Current:78    [First] [Prev] [Next] [Last]